Copyright
©The Author(s) 2020.
World J Diabetes. Jul 15, 2020; 11(7): 293-308
Published online Jul 15, 2020. doi: 10.4239/wjd.v11.i7.293
Published online Jul 15, 2020. doi: 10.4239/wjd.v11.i7.293
Gut microbiota products | Source | Mechanism | Function | Ref. | ||
LPS | The cell wall of Gram-negative bacteria | Activates the receptor TLR4 | Increase the occurrence of inflammatory response | [59,60] | ||
SCFAs | Acetate | Carbohydrate fermentation | Activates the receptor FFAR2 | Reduce the frequency of autoimmune T cells in lymphoid tissues | FFAR2 and FFAR3 stimulate the release of GLP-1 and PYY, which improve insulin secretion. | [15,91,105] |
Propionate | Activates the receptor FFAR2 and FFAR3 | Promote intestinal gluconeogenesis | ||||
Butyrate | Activates the receptor FFAR3 | Increase the number and function of regulatory T cells | ||||
Bile acids | The microbiota from host cholesterol | Bind to the receptor TGR5 and FXR | Improve insulin sensitivity | [74,76] | ||
BCAA | Prevotella copri and Bacteroides vulgatus | Activate PI3K and increase the oxidation of free fatty acids | Increase the risk of insulin resistance | [86,87] |
- Citation: Li WZ, Stirling K, Yang JJ, Zhang L. Gut microbiota and diabetes: From correlation to causality and mechanism. World J Diabetes 2020; 11(7): 293-308
- URL: https://www.wjgnet.com/1948-9358/full/v11/i7/293.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i7.293